Incisionless targeted adeno-associated viral vector delivery to the brain by focused ultrasound-mediated intranasal administration

BACKGROUND: Adeno-associated viral (AAV) vectors are currently the leading platform for gene therapy with the potential to treat a variety of central nervous system (CNS) diseases. There are numerous methods for delivering AAVs to the CNS, such as direct intracranial injection (DI), intranasal deliv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Dezhuang, Yuan, Jinyun, Yang, Yaoheng, Yue, Yimei, Hu, Zhongtao, Fadera, Siaka, Chen, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508404/
https://www.ncbi.nlm.nih.gov/pubmed/36152518
http://dx.doi.org/10.1016/j.ebiom.2022.104277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508404/
https://www.ncbi.nlm.nih.gov/pubmed/36152518
http://dx.doi.org/10.1016/j.ebiom.2022.104277

Ejemplares similares